Xu RH - Search Results

1

Safety and efficacy of fruquintinib in patients with previously treated metastatic colorectal cancer: a phase Ib study and a randomized double-blind phase II study.

Xu RH, Li J, Bai Y, Xu J, Liu T, Shen L, Wang L, Pan H, Cao J, Zhang D, Fan S, Hua Y, Su W. Xu RH, et al. Among authors: xu j. J Hematol Oncol. 2017 Jan 19;10(1):22. doi: 10.1186/s13045-016-0384-9. J Hematol Oncol. 2017. PMID: 28103904 Free PMC article. Clinical Trial.

2

[Expression of glycoprotein 90K in non-Hodgkin's lymphoma and its clinical significance].

Zhang DS, Ding Y, Li YH, Xu RH, Wang B, Zhang XS, Zeng J, Liang HZ, Jiang WQ. Zhang DS, et al. Among authors: xu rh. Ai Zheng. 2005 Aug;24(8):1006-10. Ai Zheng. 2005. PMID: 16086883 Chinese.

3

[Prognostic analysis of 220 colorectal cancer patients with synchronous liver metastases].

He YF, Li YH, Zhang DS, Xiang XJ, Xu RH, Pan ZZ, Zhou ZW, Jiang WQ, He YJ, Wan DS. He YF, et al. Among authors: xu rh. Ai Zheng. 2006 Sep;25(9):1153-7. Ai Zheng. 2006. PMID: 16965661 Chinese.

4

[Efficacy of CPT-11 combined 5-FU/CF (FOLFIRI) regimen on advanced colorectal cancer].

Luo HY, Li YH, Zhang L, Jiang WQ, Shi YX, Wang F, He YJ, Xu RH. Luo HY, et al. Among authors: xu rh. Ai Zheng. 2007 Aug;26(8):905-8. Ai Zheng. 2007. PMID: 17697557 Free article. Chinese.

5

[Efficacy of gemcitabine combined oxaliplatin on advanced pancreatic cancer].

Shi YX, Xu RH, Jiang WQ, Zhang L, Lin TY, Li YH, Xia ZJ, Luo HY, Han B, Wang F, He YJ, Guan ZZ. Shi YX, et al. Among authors: xu rh. Ai Zheng. 2007 Dec;26(12):1381-4. Ai Zheng. 2007. PMID: 18076807 Free article. Chinese.

6

[Efficacy of FORFIRI regimen on oxaliplatin-based chemotherapy-failed advanced colorectal cancer].

Li YH, Wang FH, Zhang DS, Wang ZQ, Feng F, Zhang L, Xu RH, Jiang WQ, He YJ. Li YH, et al. Among authors: xu rh. Ai Zheng. 2009 Sep;28(9):913-8. doi: 10.5732/cjc.008.10571. Ai Zheng. 2009. PMID: 19728906 Free article. Clinical Trial. Chinese.

7

[Clinical significance of a transient increase in carcinoembryonic antigen and carbohydrate antigen 19-9 in patients with metastatic colorectal cancer receiving chemotherapy].

Li YH, An X, Xiang XJ, Wang ZQ, Wang FH, Feng F, Jiang WQ, He YJ, Xu RH. Li YH, et al. Among authors: xu rh. Ai Zheng. 2009 Sep;28(9):939-44. doi: 10.5732/cjc.009.10001. Ai Zheng. 2009. PMID: 19728911 Free article. Chinese.

8

[Efficacy and prognostic analysis on surgical resection of pulmonary metastasis from colorectal cancer].

Feng F, Li YH, An X, Wang FH, Xu RH, Pan ZZ, He YJ, Wan DS. Feng F, et al. Among authors: xu rh. Zhonghua Wei Chang Wai Ke Za Zhi. 2009 Sep;12(5):471-3. Zhonghua Wei Chang Wai Ke Za Zhi. 2009. PMID: 19742336 Chinese.

9

Phase II study of capecitabine plus oxaliplatin (XELOX) as first-line treatment and followed by maintenance of capecitabine in patients with metastatic colorectal cancer.

Li YH, Luo HY, Wang FH, Wang ZQ, Qiu MZ, Shi YX, Xiang XJ, Chen XQ, He YJ, Xu RH. Li YH, et al. Among authors: xu rh. J Cancer Res Clin Oncol. 2010 Apr;136(4):503-10. doi: 10.1007/s00432-009-0682-5. Epub 2009 Sep 24. J Cancer Res Clin Oncol. 2010. PMID: 19777259 Clinical Trial.

10

[Clinical features of hypersensitivity reactions to oxaliplatin among Chinese colorectal cancer patients].

Zhao Y, An X, Xiang XJ, Feng F, Wang FH, Wang ZQ, Xu RH, He YJ, Li YH. Zhao Y, et al. Among authors: xu rh. Chin J Cancer. 2010 Jan;29(1):102-5. doi: 10.5732/cjc.009.10179. Chin J Cancer. 2010. PMID: 20038320 Free article. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

749 results

Search Page

Filters